Screening for extended-spectrum β-lactamase-producing enterobacteriaceae among high-risk patients and rates of subsequent bacteremia

Clinical Infectious Diseases

Volumn 45, Issue 7, 2007, Pages 846-852

  Reddy, Pravani ^a,d   Malczynski, M ^a   Obias, A ^a   Reiner, S ^b   Jin, N ^c   Huang, J ^c   Noskin, G A ^a,b   Zembower, T ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Division of Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; BETA LACTAMASE;

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; EMERGENCY WARD; ENTEROBACTERIACEAE; HEALTH CARE FACILITY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECTUM; SCREENING; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENTEROBACTER INFECTION; ENTEROCOCCUS; ENZYMOLOGY; HEALTH SURVEY; HETEROZYGOTE; HOSPITAL PATIENT; MASS SCREENING; METABOLISM; METHODOLOGY; MICROBIOLOGY; PREVALENCE; STATISTICS; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARRIER STATE; CHICAGO; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOCCUS; HUMANS; INPATIENTS; MASS SCREENING; PREVALENCE; RECTUM; SENTINEL SURVEILLANCE; VANCOMYCIN RESISTANCE;

EID: 34848873430     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/521260     Document Type: Article

References (26)

1. National Nosocomial Infections Surveillance (NNIS). NNIS system report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003; 31:481-98.
2. Turner PJ. Extended-spectrum β-lactamases. Clin Infect Dis 2005; 41:S273-5.
3. Kim BN, Woo JH, Kim MN, Ryu J, Kim YS. Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 2002; 52:99-106.
4. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-beta- lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006; 50:1257-62.
5. Ariffin H, Navaratnam P, Mohamed M, et al. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia. Int J Infect Dis 2000; 4:21-5.
6. Paterson DL, Ko WC, Von Gottberg A, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 2004; 39:31-7.
7. Lucet JC, Decre D, Fichelle A, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis 1999; 29:1411-8.
8. Pena C, Pujol M, Ardanuy C, et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J Hosp Infect 2001; 47:53-9.
9. Troche G, Joly LM, Guibert M, Zazzo JF. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol 2005; 26:161-5.
10. Asensio A, Oliver A, Gonzalez-Diego P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000;30:55-60.
11. Gardam MA, Burrows LL, Kus JV, et al. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis 2002; 186:1754-60.
12. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004; 25:838-41.
13. Hacek DM, Trick WE, Collins SM, Noskin GA, Peterson LR. Comparison of the Rodac imprint method to selective enrichment broth for recovery of vancomycin-resistant enterococci and drug-resistant Enterobacteriaceae from environmental surfaces. J Clin Microbiol 2000; 38:4646-8.
14. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing. 12th ed. Wayne, Pa: NCCLS, 2002.
15. Lim MS, Marshall CL, Spelman D. Carriage of multiple subtypes of methicillin-resistant Staphylococcus aureus by intensive care unit patients. Infect Control Hosp Epidemiol 2006; 27:1063-7.
16. Harris AD, Nemoy L, Johnson JA, et al. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 2004; 25:105-8.
17. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol 2006; 44:3318-24.
18. Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 2002; 23:254-60.
19. Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 2005; 24:17-22.
20. Pena C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997; 35:9-16.
21. Ho PL, Chan WM, Tsang KW, Wong SS, Young K. Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes. Scand J Infect Dis 2002; 34:567-73.
22. Martins IS, Moreira BM, Riley LW, Santoro-Lopes G. Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection among renal transplant recipients. J Hosp Infect 2006; 64:305-8.
23. Christiaens G, Ciccarella Y, Damas P, et al. Prospective survey of digestive tract colonization with Enterobacteriaceae that produce extended-spectrum beta-lactamases in intensive care units. J Hosp Infect 2006; 62:386-8.
24. Ben-Ami R, Schwaber MJ, Navon-Venezia S, et al. Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006; 42:925-34.
25. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281:517-23.
26. Kola A, Holst M, Chaberny IF, et al. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect 2007; 66:46-51.